Sutent Gains Indication for Advanced Pancreatic Tumors - ONA
Links shared publicly online about this topic.
- 272total visits
Sutent Gains Indication for Advanced Pancreatic Tumors - ONA
View full resource at oncologynurseadvisor.com
Tags: Pancreatic Disease, Disease and Condition, FDA, Pfizer, disease
Most Recently Shared on May 23, 2011 at 2:50 pm By:
Sutent Gains Indication for Advanced Pancreatic Tumors http://goo.gl/fb/AhvBJ
Sutent Gains Indication for Advanced Pancreatic Tumors - MPR
empr.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on May 23, 2011 at 2:35 pm By:
MPR News: Sutent Gains Indication for Advanced Pancreatic Tumors: The FDA has approved Sutent (sunitinib malate;... http://bit.ly/klWR8Y
Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors
medicalnewstoday.com — “The Pfizer drug Sutent® (sunitinib) has been approved for the treatment of advanced pancreatic neuroendocrine tumors by the U.S. Food and Drug Administration (FDA). Sutent® is the second t” View full resource at medicalnewstoday.com
Most Recently Shared on May 21, 2011 at 7:05 am By:
MNT Pancreatic Can Health News
Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors http://mnt.to/3Wb8 #pancreaticcancer
Novartis Gains FDA Approval for Afinitor As First New Treatment in Nearly Three Decades for Patients With Advanced Pancreatic NET
drugs.com — “Afinitor (everolimus) is used to treat advanced kidney cancer, subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis and pancreatic neuroendocrine tumors. Includes Afinitor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 7, 2011 at 5:12 am By:
Drugs and Devices OW OW Health
Novartis Gains FDA Approval for Afinitor As First New Treatment in Nearly Three Decades for Patients With ... http://bit.ly/kYPfZa #drug
Novartis Gains FDA Approval for Afinitor As First New Treatment in Nearly Three Decades for Patients With Advanced Pancreatic NET
drugs.com — “Afinitor (everolimus) is used to treat advanced kidney cancer, subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis and pancreatic neuroendocrine tumors. Includes Afinitor side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 7, 2011 at 4:59 am By:
FDA Approves Afinitor as New Treatment for Patients With Advanced Pancreatic NET - http://bit.ly/kVd3tE
Advertisement
